Mariner, LLC Eq Rx, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.66 - $2.31 $18,489 - $25,728	-11,138 Reduced 39.04%	17,392 $38,000
Q2 2023 Aug 11, 2023	BUY	$1.61 - $1.96 $15,190 - $18,492	9,435 Added 49.41%	28,530 $53,000
Q1 2023 May 12, 2023	SELL	$1.8 - $2.83 $1,153 - $1,814	-641 Reduced 3.25%	19,095 $37,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $206,039 - $552,788	-100,507 Reduced 83.59%	19,736 $49,000
Q3 2022 Nov 10, 2022	BUY	$0.94 - $5.99 $113,028 - $720,255	120,243 New	120,243 $595,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.